Should we believe the benefit of intravenous erythromycin in critically ill adults with gastric feeding intolerance? Reinspecting the pieces of evidence from a series of meta-analyses.
Yi-Ting ChenKuan-Yu TaiPei-Chun LaiYen-Ta HuangPublished in: JPEN. Journal of parenteral and enteral nutrition (2022)
The effect of intravenous erythromycin in feeding intolerance for critically ill adults remained inconclusive, with very low certainty of evidence. Further large-scale randomized controlled trials with increased rigor are warranted to provide a solid conclusion.